Steven Cohen Emergent Bio Solutions Inc. Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$3.17 - $7.91 $141,949 - $354,201	44,779 New	44,779 $152,000
Q1 2021 May 17, 2021	SELL	$86.23 - $125.19 $4.8 Million - $6.97 Million	-55,661 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$79.17 - $111.47 $4.41 Million - $6.2 Million	55,661 New	55,661 $4.99 Million
Q4 2019 Feb 14, 2020	SELL	$51.21 - $59.06 $128,025 - $147,650	-2,500 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$40.6 - $57.2 $89,320 - $125,840	2,200 Added 733.33%	2,500 $131,000
Q2 2019 Aug 14, 2019	BUY	$39.92 - $53.86 $11,976 - $16,158	300 New	300 $14,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.